Telix Pharmaceuticals Limited ADR (TLX) Stock Price, Quote & News

Company Profile

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9093 3855

Website: telixpharma.com

Address:

55 Flemington Road, Level 4, North Melbourne, Australia

80sActionHero Sep. 11 at 8:03 PM

$TLX Market is closed and no press release. Looks like a strategic delay for when after hours trading ends.

1 · Reply

Hw1313 Sep. 11 at 5:07 PM

$TLX would be pretty disappointing to have another CRL especially since the first was for just manufacturing issues

0 · Reply

RomuloSkagen Sep. 11 at 4:31 PM

$TLX I expect a trading halt will be the first sign of a decision. That’s not negative. It’s normal. Since it’s already past noon I think we may not get the answer until after hours. Holiday week so they’re probably behind at FDA.

0 · Reply

OzPaz Sep. 11 at 2:25 PM

$TLX I think its dropping bc no decision yet, opens the door to fear and short attacks. I wouldn't make a move until FDA decision. I hold only 1100 shares but watching closely. GL to all

0 · Reply

RhymeZz Sep. 11 at 1:42 PM

$TLX why is this dropping ?

1 · Reply

GJ_Rockabilt Sep. 10 at 8:13 PM

$TLX Is this a sign of FAILURE?! I don't think so... ⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️

0 · Reply

GJ_Rockabilt Sep. 10 at 8:04 PM

$TLX Volume nearly doubled Average Volume, today.

0 · Reply

GJ_Rockabilt Sep. 10 at 7:34 PM

$TLX According to Fintel, "Off-Exchange Short Volume Ratio: 66.29 % - source: FINRA (inc. Dark Pool volume)." That nearly doubles yesterday's. It looks to me like Institutions & MMs are trying to create more fear than there already is to shake out loose hands. I will take my chances. There is up to a 15% chance I am doing the wrong thing, according to Microsoft CoPilot, yesterday. I can't imagine how high my Price would be if I tried to Buy in, tomorrow, if Approved. Oh well, if I end up Holding the Bag. Plenty of Pipeline in this one.

0 · Reply

GJ_Rockabilt Sep. 10 at 4:42 PM

$TLX Interactive Brokers shows 5 Analysts' Consensus Target Price (PT) of $21.

0 · Reply

GJ_Rockabilt Sep. 10 at 8:50 AM

$TLX Happy PDUFA Eve to all 231 of you Stocktwits Watchers. I'm fully extended here, already.

0 · Reply

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

2026-09-02T08:01:27.000Z - 11 days ago

Telix Completes Patient Enrollment In BiPASS Trial, Aligns With FDA On NDA Filing; Stock Up

2026-09-02T02:40:58.000Z - 11 days ago

6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More

Sep 1, 2026, 6:18 PM EDT - 12 days ago

Market Cap	3.84B
Revenue (ttm)	803.79M
Net Income (ttm)	-7.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	165.28
Profit Margin	-0.89%
Debt to Equity Ratio	1.06

Volume	415,300
Avg Vol	156,762
Day's Range	N/A - N/A
Shares Out	339.78M
Stochastic %K	29%
Beta	-0.17
Analysts	Strong Sell
Price Target	$20.80